Smith & Nephew plc (LON:SN)
London · Delayed Price · Currency is GBP · Price in GBp 1,264.00
-18.00 (-1.40%)
Nov 13, 2025, 4:36 PM BST
Smith & Nephew Market Cap
Smith & Nephew has a market cap or net worth of 10.71 billion as of November 13, 2025. Its market cap has increased by 27.10% in one year.
Market Cap
10.71B
Enterprise Value
12.74B
Revenue
4.33B
Ranking
n/a
PE Ratio
31.06
Stock Price
1,264.00
Market Cap Chart
Since December 31, 1985, Smith & Nephew's market cap has increased from 819.93M to 10.71B, an increase of 1,206.78%. That is a compound annual growth rate of 6.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 10.71B | 23.93% |
| Dec 31, 2024 | 8.65B | -7.88% |
| Dec 29, 2023 | 9.39B | -2.72% |
| Dec 30, 2022 | 9.65B | -15.11% |
| Dec 31, 2021 | 11.36B | -14.01% |
| Dec 31, 2020 | 13.22B | -17.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 203.55B |
| GSK plc | 71.18B |
| Haleon | 32.34B |
| ConvaTec Group | 4.63B |
| Hikma Pharmaceuticals | 3.44B |
| HUTCHMED (China) | 1.97B |
| Genus | 1.58B |
| Oxford Nanopore Technologies | 1.33B |